27-hydroxycholesterol has been researched along with isoniazid in 1 studies
| Studies (27-hydroxycholesterol) | Trials (27-hydroxycholesterol) | Recent Studies (post-2010) (27-hydroxycholesterol) | Studies (isoniazid) | Trials (isoniazid) | Recent Studies (post-2010) (isoniazid) |
|---|---|---|---|---|---|
| 345 | 11 | 214 | 21,815 | 960 | 4,493 |
| Protein | Taxonomy | 27-hydroxycholesterol (IC50) | isoniazid (IC50) |
|---|---|---|---|
| Myeloperoxidase | Homo sapiens (human) | 4.85 | |
| Enoyl-[acyl-carrier-protein] reductase [NADH] | Mycobacterium tuberculosis H37Rv | 8.29 | |
| Putative FAD-containing monooxygenase MymA | Mycobacterium tuberculosis H37Rv | 4.9 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, TA; Franzblau, SG; Knölker, HJ; Schmidt, AW; Theumer, G | 1 |
1 other study(ies) available for 27-hydroxycholesterol and isoniazid
| Article | Year |
|---|---|
Inhibitory effect of oxygenated cholestan-3β-ol derivatives on the growth of Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Cholestanols; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxidation-Reduction; Stereoisomerism; Structure-Activity Relationship | 2013 |